Brinzolamide Intermediate (CAS 160982-10-5) | High-Quality API Synthesis Building Block
Google Search Keywords: Brinzolamide Intermediate, CAS 160982-10-5, Carbonic Anhydrase Inhibitor Intermediate, API Synthesis, Pharmaceutical Intermediates
🔬 Product Overview
Brinzolamide Intermediate (CAS 160982-10-5) is a key chemical building block in the synthesis of Brinzolamide, a carbonic anhydrase inhibitor used to treat glaucoma and ocular hypertension. This intermediate ensures efficient and scalable production of high-purity active pharmaceutical ingredients (APIs).
Primary Function: Critical precursor in Brinzolamide API manufacturing.
Applications: Pharmaceutical synthesis, generic drug development, process optimization.
✅ Key Advantages
⭐ High Yield & Purity
⚡ Process Efficiency
🌡️ Stability
📋 Applications
API Manufacturing: Core component in Brinzolamide production.
Generic Drug Development: Supports cost-effective alternatives to branded medications.
Process Chemistry: Used in route scouting and optimization studies.
🏅 Quality Certifications
Rigorously tested via HPLC, GC, and NMR (compliant with ICH Q7 and USP/EP standards).
Batch-specific Certificate of Analysis (CoA) ensures traceability and compliance.
🌐 Market Trends
The global pharmaceutical intermediates market is expected to grow at 6.2% CAGR (2023-2030), fueled by rising demand for glaucoma therapies and generic APIs. Brinzolamide intermediates are pivotal in meeting the needs of expanding ophthalmic drug manufacturing.
🔍 Why Choose Us?
Custom synthesis and bulk order capabilities.
Fast global delivery with cold-chain support.
Expert technical guidance for API development.
China
